Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
Atherosclerosis
    February 2024
  1. BASU P, Das AA, Siddiqui KN, Mondal PC, et al
    Novel role of peptidoglycan recognition protein 2 in activating NOD2-NFkappaB inflammatory axis in coronary artery disease.
    Atherosclerosis. 2024;389:117436.
    >> Share

    January 2024
  2. XU M, Hou Z, Koyratty N, Huang C, et al
    Association between long-term exposure to ambient air pollution and lesion ischemia in patients with atherosclerosis.
    Atherosclerosis. 2024;388:117422.
    >> Share

  3. KADIYALA V, Khetpal V, Hulten EA
    Coronary artery calcium screening: He who buys what he does not need steals from himself.
    Atherosclerosis. 2024;388:117411.
    >> Share

  4. QIU Y, Hao W, Guo Y, Guo Q, et al
    The association of lipoprotein (a) with coronary artery calcification: A systematic review and meta-analysis.
    Atherosclerosis. 2024;388:117405.
    >> Share

  5. ACQUAH I, Cainzos-Achirica M, Taha MB, Lahan S, et al
    Social disadvantage, coronary artery calcium, and their interplay in the prediction of atherosclerotic cardiovascular disease events.
    Atherosclerosis. 2024;388:117355.
    >> Share

    December 2023
  6. WODAJE T, Mahdi A, Venkateshvaran A, Habel H, et al
    Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia.
    Atherosclerosis. 2023;389:117439.
    >> Share

  7. DONG JY, Iso H, Muraki I, Tanaka M, et al
    Timing of clinic visits after health checks and risk of hospitalization for cardiovascular events and all-cause death among the high-risk population.
    Atherosclerosis. 2023;388:117409.
    >> Share

  8. HARIRI E, Asbeutah AA, Malik A, Amangurbanova M, et al
    Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial.
    Atherosclerosis. 2023;387:117388.
    >> Share

  9. TZIOTZIOU A, Hartman E, Korteland SA, van der Lugt A, et al
    Mechanical wall stress and wall shear stress are associated with atherosclerosis development in non-calcified coronary segments.
    Atherosclerosis. 2023;387:117387.
    >> Share

  10. KHEIRKHAH A, Schachtl-Riess JF, Lamina C, Di Maio S, et al
    Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in White populations.
    Atherosclerosis. 2023;386:117384.
    >> Share

  11. OMORI H, Matsuo H, Fujimoto S, Sobue Y, et al
    Determination of lipid-rich plaques by artificial intelligence-enabled quantitative computed tomography using near-infrared spectroscopy as reference.
    Atherosclerosis. 2023;386:117363.
    >> Share

  12. FAHED AC, Natarajan P
    Clinical applications of polygenic risk score for coronary artery disease through the life course.
    Atherosclerosis. 2023;386:117356.
    >> Share

    November 2023
  13. BJORNSON E, Adiels M, Bergstrom G, Gummesson A, et al
    The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteins.
    Atherosclerosis. 2023 Nov 29:117397. doi: 10.1016/j.atherosclerosis.2023.117397.
    >> Share

  14. LAI Z, Wu G, Yang Y, Chen L, et al
    Interactive effects of physical activity and sarcopenia on incident ischemic heart disease: Results from a nation-wide cohort study.
    Atherosclerosis. 2023;388:117396.
    >> Share

  15. MARTIN-CAMPOS JM, Carcel-Marquez J, Llucia-Carol L, Lledos M, et al
    Causal role of lipid metabolome on the risk of ischemic stroke, its etiological subtypes, and long-term outcome: A Mendelian randomization study.
    Atherosclerosis. 2023;386:117382.
    >> Share

  16. SAKKERS TR, Mokry M, Civelek M, Erdmann J, et al
    Sex differences in the genetic and molecular mechanisms of coronary artery disease.
    Atherosclerosis. 2023;384:117279.
    >> Share

  17. CIVIERI G, Kerkhof PLM, Montisci R, Iliceto S, et al
    Sex differences in diagnostic modalities of coronary artery disease: Evidence from coronary microcirculation.
    Atherosclerosis. 2023;384:117276.
    >> Share

  18. CROOIJMANS J, Singh S, Naqshband M, Bruikman CS, et al
    Premature atherosclerosis: An analysis over 39 years in the Netherlands. Implications for young individuals in high-risk families.
    Atherosclerosis. 2023;384:117267.
    >> Share

  19. GURGOGLIONE FL, Solinas E, Pfleiderer B, Vezzani A, et al
    Coronary atherosclerotic plaque phenotype and physiopathologic mechanisms: Is there an influence of sex? Insights from intracoronary imaging.
    Atherosclerosis. 2023;384:117273.
    >> Share

  20. HOLTZMAN JN, Kaur G, Hansen B, Bushana N, et al
    Sex differences in the management of atherosclerotic cardiovascular disease.
    Atherosclerosis. 2023;384:117268.
    >> Share

  21. CHEDID G, Malik A, Daher R, Welty FK, et al
    Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease.
    Atherosclerosis. 2023;384:117168.
    >> Share

  22. KANG J, Cho Y
    Sex differences in the association between minor nonspecific ST-segment and T-wave abnormalities and coronary artery calcification.
    Atherosclerosis. 2023;384:117154.
    >> Share

  23. LU C, Donners MMPC, Karel J, de Boer H, et al
    Sex-specific differences in cytokine signaling pathways in circulating monocytes of cardiovascular disease patients.
    Atherosclerosis. 2023;384:117123.
    >> Share

  24. NELLES G, Abdelwahed YS, Alyaqoob A, Seppelt C, et al
    Spotty calcium deposits within acute coronary syndrome (ACS)-causing culprit lesions impact inflammatory vessel-wall interactions and are associated with higher cardiovascular event rates at one year follow-up: Results from the prospective translation
    Atherosclerosis. 2023;385:117284.
    >> Share

  25. PONTONE G, Rossi A, Gimelli A, Neglia D, et al
    Should we choose CT angiography first instead of SPECT/PET first for the diagnosis and management of coronary artery disease?
    Atherosclerosis. 2023;385:117315.
    >> Share

  26. RASMUSSEN KL, Luo J, Nordestgaard BG, Tybjaerg-Hansen A, et al
    APOE and vascular disease: Sequencing and genotyping in general population cohorts.
    Atherosclerosis. 2023;385:117218.
    >> Share

    October 2023
  27. LANDMESSER U, Koenig W, Leiter LA, Raal FJ, et al
    Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials.
    Atherosclerosis. 2023;386:117354.
    >> Share

  28. JUNNA N, Ruotsalainen S, Ripatti P, FinnGen, et al
    Novel Finnish-enriched variants causing severe hypercholesterolemia and their clinical impact on coronary artery disease.
    Atherosclerosis. 2023 Oct 12:117327. doi: 10.1016/j.atherosclerosis.2023.117327.
    >> Share

  29. PAGE MM, Hardikar W, Alex G, Bates S, et al
    Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand.
    Atherosclerosis. 2023 Oct 10:117305. doi: 10.1016/j.atherosclerosis.2023.117305.
    >> Share

  30. WILLIAMS C, Han D, Takagi H, Fordyce CB, et al
    Effects of renin-angiotensin-aldosterone-system inhibitors on coronary atherosclerotic plaques: The PARADIGM registry.
    Atherosclerosis. 2023;383:117301.
    >> Share

    September 2023
  31. HAMAYA R, Goto S, Hwang D, Zhang J, et al
    Machine-learning-based prediction of fractional flow reserve after percutaneous coronary intervention.
    Atherosclerosis. 2023;383:117310.
    >> Share

  32. SONG Z, Wan L, Wang W, Li Y, et al
    Daily stair climbing, disease susceptibility, and risk of atherosclerotic cardiovascular disease: A prospective cohort study.
    Atherosclerosis. 2023 Sep 16:117300. doi: 10.1016/j.atherosclerosis.2023.117300.
    >> Share

  33. LEE YH, Hsieh MT, Chang CC, Tsai YL, et al
    Improving detection of obstructive coronary artery disease with an artificial intelligence-enabled electrocardiogram algorithm.
    Atherosclerosis. 2023;381:117238.
    >> Share

  34. KWIECINSKI J, Oleksiak A, Kruk M, Zysk A, et al
    Computed tomography perfusion and angiography in patients with chronic total occlusion undergoing percutaneous coronary intervention.
    Atherosclerosis. 2023;381:117174.
    >> Share

    August 2023
  35. ZHAO JV, Fan B, Burgess S
    Using genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study.
    Atherosclerosis. 2023;381:117246.
    >> Share

  36. CASULA M, Gazzotti M, Capra ME, Olmastroni E, et al
    Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study.
    Atherosclerosis. 2023 Aug 12:117231. doi: 10.1016/j.atherosclerosis.2023.117231.
    >> Share

  37. KOSKA J, Hu Y, Furtado J, Billheimer D, et al
    Association of apolipoproteins C-I and C-II truncations with coronary heart disease and progression of coronary artery calcium: Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2023;380:117214.
    >> Share

  38. HON A, Hsu JJ, Zambrano A, Xia Y, et al
    Effects of activity levels on aortic calcification in hyperlipidemic mice as measured by microPETmicroCT.
    Atherosclerosis. 2023;380:117198.
    >> Share

  39. WANG C, Tian X, Feng X, Demuyakor A, et al
    Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history.
    Atherosclerosis. 2023;378:117118.
    >> Share

    July 2023
  40. OJEDA-RODRIGUEZ A, Alcala-Diaz JF, Rangel-Zuniga OA, Arenas-de Larriva AP, et al
    Association between telomere length and intima-media thickness of both common carotid arteries in patients with coronary heart disease: From the CORDIOPREV randomized controlled trial.
    Atherosclerosis. 2023;380:117193.
    >> Share

  41. FU Y, Yusufu M, Wang Y, He M, et al
    Association of retinal microvascular density and complexity with incident coronary heart disease.
    Atherosclerosis. 2023;380:117196.
    >> Share

  42. ADAY AW, Bagheri M, Vaitinadin NS, Mosley JD, et al
    Polygenic risk score in comparison with C-reactive protein for predicting incident coronary heart disease.
    Atherosclerosis. 2023;379:117194.
    >> Share

  43. VINK CEM, Woudstra J, Lee JM, Boerhout CKM, et al
    Sex differences in prevalence and outcomes of the different endotypes of chronic coronary syndrome in symptomatic patients undergoing invasive coronary angiography: Insights from the global ILIAS invasive coronary physiology registry.
    Atherosclerosis. 2023 Jul 8:117167. doi: 10.1016/j.atherosclerosis.2023.
    >> Share

  44. LI Z, Lin C, Cai X, Hu S, et al
    Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials.
    Atherosclerosis. 2023;379:117181.
    >> Share

  45. KRALER S, Wenzl FA, Vykoukal J, Fahrmann JF, et al
    Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis.
    Atherosclerosis. 2023;376:43-52.
    >> Share

  46. DALILA N, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A, et al
    Plasma TSH and cardiovascular disease in the general population: A Mendelian randomization study of 105,224 individuals.
    Atherosclerosis. 2023;376:26-33.
    >> Share

  47. NOORDAM R, Brochard TA, Drewes YM, Gussekloo J, et al
    Cardiovascular risk factors and major recurrent coronary events: A genetic liability study in patients with coronary artery disease in the UK Biobank.
    Atherosclerosis. 2023;376:19-25.
    >> Share

  48. HAKIM D, Pinilla-Echeverri N, Coskun AU, Pu Z, et al
    The role of endothelial shear stress, shear stress gradient, and plaque topography in plaque erosion.
    Atherosclerosis. 2023;376:11-18.
    >> Share

    June 2023
  49. TONA F, Vadori M, Civieri G, Masiero G, et al
    Association of autoantibodies targeting endothelin type-A receptors with no-reflow in ST-elevation myocardial infarction.
    Atherosclerosis. 2023 Jun 28:117179. doi: 10.1016/j.atherosclerosis.2023.
    >> Share

  50. ZHANG K, Liu C, Sha X, Yao S, et al
    Development and validation of a prediction model to predict major adverse cardiovascular events in elderly patients undergoing noncardiac surgery: A retrospective cohort study.
    Atherosclerosis. 2023;376:71-79.
    >> Share

  51. LOPEZ RODRIGUEZ M, Arasu UT, Kaikkonen MU
    Exploring the genetic basis of coronary artery disease using functional genomics.
    Atherosclerosis. 2023;374:87-98.
    >> Share

    May 2023
  52. DOI T, Langsted A, Nordestgaard BG
    Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality.
    Atherosclerosis. 2023 May 13:S0021-9150(23)00204.
    >> Share

  53. KUEHNEMUND L, Lange SA, Feld J, Padberg JS, et al
    Sex disparities in guideline-recommended therapies and outcomes after ST-elevation myocardial infarction in a contemporary nationwide cohort of patients over an eight-year period.
    Atherosclerosis. 2023;375:30-37.
    >> Share

  54. KUMAR A, Stillman AE, Chatzizisis YS
    Coronary plaque phenotyping with cardiac CTA: Separating the signal from the noise.
    Atherosclerosis. 2023;373:66-68.
    >> Share

  55. LEMIEUX I, Despres JP
    Weight gain with age and coronary atherosclerosis: Only the tip of a deadly iceberg.
    Atherosclerosis. 2023;373:55-57.
    >> Share

  56. YANG S, Lesina K, Doh JH, Jegere S, et al
    Long-term prognostic implications of hemodynamic and plaque assessment using coronary CT angiography.
    Atherosclerosis. 2023;373:58-65.
    >> Share

  57. BERGSTROM G, Rosengren A, Bacsovics Brolin E, Brandberg J, et al
    Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPIS.
    Atherosclerosis. 2023;373:46-54.
    >> Share

    April 2023
  58. NAYFEH M, Ahmed AI, Alahdab F, Al Rifai M, et al
    No contrast? No problem! Value in assessing pericoronary fat in non-contrast studies.
    Atherosclerosis. 2023;370:3-4.
    >> Share

  59. TAKAHASHI D, Fujimoto S, Nozaki YO, Kudo A, et al
    Validation and clinical impact of novel pericoronary adipose tissue measurement on ECG-gated non-contrast chest CT.
    Atherosclerosis. 2023;370:18-24.
    >> Share

    March 2023
  60. YANG XH, Zhang BL, Cheng Y, Fu SK, et al
    Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis.
    Atherosclerosis. 2023;371:21-31.
    >> Share

  61. TADA H, Nomura A, Nohara A, Usui S, et al
    Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia.
    Atherosclerosis. 2023 Mar 17:S0021-9150(23)00103.
    >> Share

  62. MOK Y, Wang F, Ballew SH, Menez S, et al
    Kidney function, bone-mineral metabolism markers, and calcification of coronary arteries, aorta, and cardiac valves in older adults.
    Atherosclerosis. 2023;368:35-43.
    >> Share

    February 2023
  63. KATRA P, Hennings V, Nilsson J, Engstrom G, et al
    Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort.
    Atherosclerosis. 2023;366:1-7.
    >> Share

  64. DI GIOVANNI G, Kataoka Y, Bubb K, Nelson AJ, et al
    Impact of lipid lowering on coronary atherosclerosis moving from the lumen to the artery wall.
    Atherosclerosis. 2023;367:8-14.
    >> Share

  65. FENG X, Zhang C, Huang X, Liu J, et al
    Machine learning improves mortality prediction in three-vessel disease.
    Atherosclerosis. 2023;367:1-7.
    >> Share

    January 2023
  66. MONTONE RA, Rinaldi R, Bonanni A, Severino A, et al
    Impact of air pollution on ischemic heart disease: Evidence, mechanisms, clinical perspectives.
    Atherosclerosis. 2023;366:22-31.
    >> Share

  67. TSABAN G, Peles I, Barrett O, Abramowitz Y, et al
    Nonobstructive coronary atherosclerosis is associated with adverse prognosis among patients diagnosed with myocardial infarction without obstructive coronary arteries.
    Atherosclerosis. 2023;366:8-13.
    >> Share

  68. DORAJOO R, Ihsan MO, Liu W, Lim HY, et al
    Vascular smooth muscle cells in low SYNTAX scores coronary artery disease exhibit proinflammatory transcripts and proteins correlated with IL1B activation.
    Atherosclerosis. 2023;365:15-24.
    >> Share

    December 2022
  69. TAY KY, Wu KX, Chioh FWJ, Autio MI, et al
    Trans-interaction of risk loci 6p24.1 and 10q11.21 is associated with endothelial damage in coronary artery disease.
    Atherosclerosis. 2022;362:11-22.
    >> Share

  70. LIND L, Markstad H, Ahlstrom H, Angeras O, et al
    Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study.
    Atherosclerosis. 2022;362:1-10.
    >> Share

  71. GOWDA SGB, Gowda D, Hou F, Chiba H, et al
    Temporal lipid profiling in the progression from acute to chronic heart failure in mice and ischemic human hearts.
    Atherosclerosis. 2022;363:30-41.
    >> Share

  72. MEHTA PK, Huang J, Levit RD, Malas W, et al
    Ischemia and no obstructive coronary arteries (INOCA): A narrative review.
    Atherosclerosis. 2022;363:8-21.
    >> Share

  73. JINNOUCHI H, Sakakura K, Taniguchi Y, Tsukui T, et al
    Impact of ultrasound reverberation in calcified coronary arteries: Intravascular ultrasound study.
    Atherosclerosis. 2022;363:1-7.
    >> Share

  74. ZIERFUSS B, Hobaus C, Feldscher A, Hannes A, et al
    Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization.
    Atherosclerosis. 2022;363:94-101.
    >> Share

  75. RIKHI R, Hammoud A, Ashburn N, Snavely AC, et al
    Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2022;363:102-108.
    >> Share

    November 2022
  76. AHN HJ, Lee H, Park HE, Han D, et al
    Changes in metabolic syndrome burden and risk of coronary artery calcification progression in statin-naive young adults.
    Atherosclerosis. 2022;360:27-33.
    >> Share

  77. OKADA K, Kikuchi S, Kuji S, Nakayama N, et al
    Impact of early intervention with alogliptin on coronary plaque regression and stabilization in patients with acute coronary syndromes.
    Atherosclerosis. 2022;360:1-7.
    >> Share

  78. SEKIMOTO T, Mori H, Koba S, Arai T, et al
    Clinical features and lipid profiles of plaque erosion over lipid-rich plaque versus fibrous plaque in patients with acute coronary syndrome.
    Atherosclerosis. 2022;360:47-52.
    >> Share

    October 2022
  79. YUAN D, Wang P, Jia S, Zhang C, et al
    Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2022 Oct 25. pii: S0021-9150(22)01495.
    >> Share

  80. TESCHE C, Bauer MJ, Straube F, Rogowski S, et al
    Association of epicardial adipose tissue with coronary CT angiography plaque parameters on cardiovascular outcome in patients with and without diabetes mellitus.
    Atherosclerosis. 2022 Oct 17. pii: S0021-9150(22)01477.
    >> Share

  81. WU S, Yang YM, Zhu J, Xu W, et al
    Impact of glycemic gap on 30-day adverse outcomes in patients with acute ST-segment elevation myocardial infarction.
    Atherosclerosis. 2022;360:34-41.
    >> Share

  82. SUN Y, Zhang H, Wang B, Chen C, et al
    Joint exposure to positive affect, life satisfaction, broad depression, and neuroticism and risk of cardiovascular diseases: A prospective cohort study.
    Atherosclerosis. 2022;359:44-51.
    >> Share

    September 2022
  83. DE MARCHIS GM, Dittrich TD, Malik R, Zietz AV, et al
    Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.
    Atherosclerosis. 2022 Sep 26. pii: S0021-9150(22)01433.
    >> Share

  84. NONG JC, You W, Xu T, Meng PN, et al
    Dynamic natural morphologies and component changes in nonculprit subclinical atherosclerosis in patients with acute coronary syndrome at 1-year follow-up and clinical significance at 3-year follow-up.
    Atherosclerosis. 2022;356:1-8.
    >> Share

    August 2022
  85. SCHIANO C, Balbi C, Burrello J, Ruocco A, et al
    De novo DNA methylation induced by circulating extracellular vesicles from acute coronary syndrome patients.
    Atherosclerosis. 2022;354:41-52.
    >> Share

  86. CICERO AFG, Salvetti M
    Peripheral artery disease: A highly prevalent untreated and uncontrolled independent cardiovascular disease.
    Atherosclerosis. 2022;354:55-56.
    >> Share

  87. KUMAR R, Bainey KR
    Percutaneous coronary intervention with peripheral artery disease in the contemporary era: Still life or limb?
    Atherosclerosis. 2022;355:45-47.
    >> Share

  88. PINXTERHUIS TH, Ploumen EH, Zocca P, Doggen CJM, et al
    Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials.
    Atherosclerosis. 2022;355:52-59.
    >> Share

    July 2022
  89. KIM C, Choi DW, Lee SJ, Suh Y, et al
    Benefit and risk of prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with chronic kidney disease: A nationwide cohort study.
    Atherosclerosis. 2022;352:69-75.
    >> Share

  90. ALFADDAGH A, Kapoor K, Dardari ZA, Bhatt DL, et al
    Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.
    Atherosclerosis. 2022;353:11-19.
    >> Share

  91. AL RIFAI M, Ahmed AI, Al-Mallah MH
    Evaluating coronary atherosclerosis progression among South Asians.
    Atherosclerosis. 2022;353:30-32.
    >> Share

  92. BHATIA HS, Lin F, Thomas IC, Denenberg J, et al
    Coronary artery calcium incidence and changes using direct plaque measurements: The MASALA study.
    Atherosclerosis. 2022;353:41-46.
    >> Share

  93. POST WS, Haberlen SA, Witt MD, Zhang L, et al
    Suboptimal HIV suppression is associated with progression of coronary artery stenosis: The Multicenter AIDS Cohort Study (MACS) longitudinal coronary CT angiography study.
    Atherosclerosis. 2022;353:33-40.
    >> Share

    June 2022
  94. KYTO V, Saraste A, Tornio A
    Early statin use and cardiovascular outcomes after myocardial infarction: A population-based case-control study.
    Atherosclerosis. 2022;354:8-14.
    >> Share

  95. CLARKE R, Hammami I, Sherliker P, Valdes-Marquez E, et al
    Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
    Atherosclerosis. 2022;354:15-22.
    >> Share

  96. BOAKYE E, Dardari Z, Obisesan OH, Osei AD, et al
    Sex-and race-specific burden of aortic valve calcification among older adults without overt coronary heart disease: The Atherosclerosis Risk in Communities Study.
    Atherosclerosis. 2022 Jun 13. pii: S0021-9150(22)00290.
    >> Share

  97. CALBUREAN PA, Grebenisan P, Nistor IA, Pal K, et al
    Prediction of 3-year all-cause and cardiovascular cause mortality in a prospective percutaneous coronary intervention registry: Machine learning model outperforms conventional clinical risk scores.
    Atherosclerosis. 2022;350:33-40.
    >> Share

  98. ROESNER C, Goeller M, Raaz-Schrauder D, Dey D, et al
    Differences of inflammatory cytokine profile in patients with vulnerable plaque: A coronary CTA study.
    Atherosclerosis. 2022;350:25-32.
    >> Share

  99. GORDIN D, Bjornstad P, van Raalte DH
    Lipids in CKD: What do we actually know?
    Atherosclerosis. 2022;350:97-99.
    >> Share

  100. SORENSEN IM, Bisgaard LS, Bjergfelt SS, Ballegaard EL, et al
    The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease.
    Atherosclerosis. 2022;350:109-118.
    >> Share

  101. GROENLAND EH, Heidemann BE, van der Laan SW, van Setten J, et al
    Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease.
    Atherosclerosis. 2022;350:102-108.
    >> Share

    May 2022
  102. SCHNITZER F, Forer L, Schonherr S, Gieger C, et al
    Association between a polygenic and family risk score on the prevalence and incidence of myocardial infarction in the KORA-F3 study.
    Atherosclerosis. 2022;352:10-17.
    >> Share

  103. WELSH RC, Kay R, Bainey KR
    Evaluation and management of chronic kidney disease patients with stable ischemic heart disease.
    Atherosclerosis. 2022 May 16. pii: S0021-9150(22)00241.
    >> Share

  104. MATSUSHITA K, Gao Y, Sang Y, Ballew SH, et al
    Comparative mortality according to peripheral artery disease and coronary heart disease/stroke in the United States.
    Atherosclerosis. 2022 May 8. pii: S0021-9150(22)00221.
    >> Share

  105. WOLTERS FJ, Hilal S, Leening MJG, Kavousi M, et al
    Plasma amyloid-beta40 in relation to subclinical atherosclerosis and cardiovascular disease: A population-based study.
    Atherosclerosis. 2022;348:44-50.
    >> Share

  106. DANG AT, Turner AW, Lau P, Mohottalage D, et al
    A novel anti-inflammatory role links the CARS2 locus to protection from coronary artery disease.
    Atherosclerosis. 2022;348:8-15.
    >> Share

  107. MATSUOKA S, Kaneko H, Okada A, Itoh H, et al
    Association of retinal atherosclerosis assessed using Keith-Wagener-Barker system with incident heart failure and other atherosclerotic cardiovascular disease: Analysis of 319,501 individuals from the general population.
    Atherosclerosis. 2022;348:68-74.
    >> Share

  108. GRUNEIS R, Lamina C, Di Maio S, Schonherr S, et al
    The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.
    Atherosclerosis. 2022;349:151-159.
    >> Share

  109. LI Q, Chen Y, Yu L, Zhu L, et al
    The relationship between lipoprotein(a) and cardiovascular events in acute coronary syndrome patients with and without chronic kidney disease.
    Atherosclerosis. 2022;349:204-210.
    >> Share

  110. LEE H, Park KS, Jeon YJ, Park EJ, et al
    Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals.
    Atherosclerosis. 2022;349:190-195.
    >> Share

    April 2022
  111. CHO IY, Yoo JE, Han K, Kim D, et al
    Frequent drinking is more predictive of ischemic stroke than binge drinking, but not of myocardial infarction.
    Atherosclerosis. 2022;350:65-72.
    >> Share

  112. TENG H, Gao Y, Wu C, Zhang H, et al
    Prevalence and patient characteristics of familial hypercholesterolemia in a Chinese population aged 35-75 years: Results from China PEACE Million Persons Project.
    Atherosclerosis. 2022;350:58-64.
    >> Share

  113. NAKAMURA H, Kataoka Y, Nicholls SJ, Puri R, et al
    Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
    Atherosclerosis. 2022 Apr 10. pii: S0021-9150(22)00166.
    >> Share

  114. JUKEMA RA, de Winter RW, van Diemen PA, Driessen RS, et al
    The relation of RAAS activity and endothelin-1 levels to coronary atherosclerotic burden and microvascular dysfunction in chest pain patients.
    Atherosclerosis. 2022;347:47-54.
    >> Share

  115. AHMED AI, Raggi P, Al-Mallah MH
    Primary vs. secondary prevention and coronary artery calcium: Shades of grey.
    Atherosclerosis. 2022;347:68-69.
    >> Share

  116. DZAYE O, Razavi AC, Michos ED, Mortensen MB, et al
    Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial.
    Atherosclerosis. 2022;347:70-76.
    >> Share

  117. MAURICIO R, Singh K, Sanghavi M, Ayers CR, et al
    Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study.
    Atherosclerosis. 2022;346:46-52.
    >> Share

  118. KATSIKI N, Raggi P, Korosoglou G
    Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?
    Atherosclerosis. 2022;346:79-81.
    >> Share

  119. YAMAGUCHI M, Hoshino M, Sugiyama T, Kanaji Y, et al
    Association of near-infrared spectroscopy-defined lipid rich plaque with lesion morphology and peri-coronary inflammation on computed tomography angiography.
    Atherosclerosis. 2022;346:109-116.
    >> Share

    March 2022
  120. CHO IY, Chang Y, Sung E, Kim Y, et al
    Fasting ketonuria is inversely associated with coronary artery calcification in non-diabetic individuals.
    Atherosclerosis. 2022;348:1-7.
    >> Share

  121. LESZEK A, Poli L, Zbinden S, Godoy LC, et al
    Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis.
    Atherosclerosis. 2022 Mar 4. pii: S0021-9150(22)00106.
    >> Share

  122. CHRISTENSEN DM, Strange JE, Phelps M, Schjerning AM, et al
    Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021.
    Atherosclerosis. 2022;346:63-67.
    >> Share

  123. BAJAJ R, Eggermont J, Grainger SJ, Raber L, et al
    Machine learning for atherosclerotic tissue component classification in combined near-infrared spectroscopy intravascular ultrasound imaging: Validation against histology.
    Atherosclerosis. 2022;345:15-25.
    >> Share

  124. ASZTALOS BF, Hauser TH, Goldfine AB, Welty FK, et al
    The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
    Atherosclerosis. 2022;345:1-6.
    >> Share

  125. KOBO O, Saada M, Laanmets P, Karageorgiev D, et al
    Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry.
    Atherosclerosis. 2022;344:71-77.
    >> Share

  126. KOSHY AN, Nerlekar N, Gow PJ, Lim R, et al
    A prospective natural history study of coronary atherosclerosis following liver transplantation.
    Atherosclerosis. 2022;344:40-48.
    >> Share

  127. KUNIO M, Gardecki JA, Watanabe K, Nishimiya K, et al
    Histopathological correlation of near infrared autofluorescence in human cadaver coronary arteries.
    Atherosclerosis. 2022;344:31-39.
    >> Share

  128. FUJIMOTO D, Otake H, Kawamori H, Toba T, et al
    Cholesterol uptake capacity: A new measure of high-density lipoprotein functionality as a predictor of subsequent revascularization in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2022;345:44-50.
    >> Share

    February 2022
  129. PASZEK E, Pociask E, Zabczyk M, Piorkowski A, et al
    Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
    Atherosclerosis. 2022 Feb 11. pii: S0021-9150(22)00078.
    >> Share

  130. STONE PH, Coskun AU
    Coronary angiography-based shear stress computation to identify high-risk coronary artery plaques: Are we there yet?
    Atherosclerosis. 2022;342:25-27.
    >> Share

  131. WENTZEL JJ, Papafaklis MI, Antoniadis AP, Takahashi S, et al
    Sex-related differences in plaque characteristics and endothelial shear stress related plaque-progression in human coronary arteries.
    Atherosclerosis. 2022;342:9-18.
    >> Share

  132. HULTEN EA, Gallagher RM
    Coronary revascularization for patients with non-ST elevation myocardial infarction and chronic kidney disease: Better three hours too soon than a minute too late?
    Atherosclerosis. 2022 Feb 1. pii: S0021-9150(22)00042.
    >> Share

    January 2022
  133. GUDMUNDSSON EF, Bjornsdottir G, Sigurdsson S, Andersen K, et al
    Carotid plaque is strongly associated with coronary artery calcium and predicts incident coronary heart disease in a population-based cohort.
    Atherosclerosis. 2022 Jan 23. pii: S0021-9150(22)00043.
    >> Share

  134. YOSHIDA Y, Chen Z, Baudier RL, Krousel-Wood M, et al
    Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.
    Atherosclerosis. 2022;344:13-19.
    >> Share

  135. HE X, Dong B, Liang W, Wu Y, et al
    Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
    Atherosclerosis. 2022;344:1-6.
    >> Share

  136. ANNEMA W, Gawinecka J, Muendlein A, Saely CH, et al
    Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease.
    Atherosclerosis. 2022;341:27-33.
    >> Share

  137. LEE YH, Tsai TH, Chen JH, Huang CJ, et al
    Machine learning of treadmill exercise test to improve selection for testing for coronary artery disease.
    Atherosclerosis. 2022;340:23-27.
    >> Share

  138. MA WF, Hodonsky CJ, Turner AW, Wong D, et al
    Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets.
    Atherosclerosis. 2022;340:12-22.
    >> Share

    December 2021
  139. ZHANG H, Yi M, Wang Y, Zhang Y, et al
    Air pollution and recurrence of cardiovascular events after ST-segment elevation myocardial infarction.
    Atherosclerosis. 2021;342:1-8.
    >> Share

  140. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Outcome of early versus delayed invasive strategy in patients with non-ST-segment elevation myocardial infarction and chronic kidney disease not on dialysis.
    Atherosclerosis. 2021 Dec 1. pii: S0021-9150(21)01463.
    >> Share

  141. ZEB I, Jorgensen NW, Blumenthal RS, Burke GL, et al
    Association of inflammatory markers and lipoprotein particle subclasses with progression of coronary artery calcium: The multi-ethnic study of atherosclerosis.
    Atherosclerosis. 2021;339:27-34.
    >> Share

  142. DI GIORGI N, Michelucci E, Smit JM, Scholte AJHA, et al
    A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome.
    Atherosclerosis. 2021;339:1-11.
    >> Share

  143. DZAYE O, Berning P, Dardari ZA, Berman DS, et al
    Coronary artery calcium is associated with long-term mortality from lung cancer: Results from the Coronary Artery Calcium Consortium.
    Atherosclerosis. 2021;339:48-54.
    >> Share

    November 2021
  144. LOH WJ, Chang X, Aw TC, Phua SK, et al
    Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population.
    Atherosclerosis. 2021 Nov 26. pii: S0021-9150(21)01446.
    >> Share

  145. CANDREVA A, Pagnoni M, Rizzini ML, Mizukami T, et al
    Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography.
    Atherosclerosis. 2021 Nov 16. pii: S0021-9150(21)01437.
    >> Share

  146. VERDOIA M, De Luca G
    Reply to: "Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead".
    Atherosclerosis. 2021;336:49-50.
    >> Share

  147. ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
    Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead.
    Atherosclerosis. 2021;336:48.
    >> Share

  148. WANG FM, Yang C, Ballew SH, Kalbaugh CA, et al
    Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: The Atherosclerosis Risk in Communities (ARIC) study.
    Atherosclerosis. 2021;336:39-47.
    >> Share

    October 2021
  149. MAHENDIRAN T, Klingenberg R, Nanchen D, Gencer B, et al
    CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients.
    Atherosclerosis. 2021;335:77-83.
    >> Share

  150. MARTINEZ-CEBALLOS MA, Sinning Rey JC, Alzate-Granados JP, Mendoza-Pinto C, et al
    Coronary calcium in autoimmune diseases: A systematic literature review and meta-analysis.
    Atherosclerosis. 2021;335:68-76.
    >> Share

  151. KIM H, Park JT, Lee J, Jung JY, et al
    The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease.
    Atherosclerosis. 2021;335:53-61.
    >> Share

  152. DOBIASOVA M
    Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors".
    Atherosclerosis. 2021;335:148.
    >> Share

  153. NEGRINI S, von Eckardstein A
    Reply to: "Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors"".
    Atherosclerosis. 2021;335:149.
    >> Share

  154. VENKATARAMAN P, Huynh Q, Nicholls SJ, Stanton T, et al
    Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial.
    Atherosclerosis. 2021;334:57-65.
    >> Share

  155. HAQUE W, Grandhi GR, Kanaya AM, Kandula NR, et al
    Implications of the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines and potential value of the coronary artery calcium score among South Asians in the US: The Mediators of Atherosclerosis in South Asians Li
    Atherosclerosis. 2021;334:48-56.
    >> Share

  156. BAMBAGIONI G, Di Mario C, Torguson R, Demola P, et al
    Lipid-rich plaques detected by near-infrared spectroscopy predict coronary events irrespective of age: A Lipid Rich Plaque sub-study.
    Atherosclerosis. 2021;334:17-22.
    >> Share

  157. AHMED AI, Han Y, Al Rifai M, Alnabelsi T, et al
    Added prognostic value of plaque burden to computed tomography angiography and myocardial perfusion imaging.
    Atherosclerosis. 2021;334:9-16.
    >> Share

    September 2021
  158. KRISTIANSEN O, Sverre E, Peersen K, Fagerland MW, et al
    The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease.
    Atherosclerosis. 2021;336:23-29.
    >> Share

  159. LIU Y, Liu S, Zhao Z, Song X, et al
    Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease.
    Atherosclerosis. 2021;333:75-82.
    >> Share

  160. AGBAEDENG TA, Noubiap JJ, Mofo Mato EP, Chew DP, et al
    Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
    Atherosclerosis. 2021;333:48-55.
    >> Share

  161. ALI HJ, Al-Mallah MH
    Time for sex specific atherosclerosis risk prediction.
    Atherosclerosis. 2021;333:87-88.
    >> Share

  162. PEPE M, Napoli G, Carulli E, Moscarelli M, et al
    Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis?
    Atherosclerosis. 2021;333:24-31.
    >> Share

  163. USUI E, Matsumura M, Mintz GS, Zhou Z, et al
    Clinical outcomes of low-intensity area without attenuation and cholesterol crystals in non-culprit lesions assessed by optical coherence tomography.
    Atherosclerosis. 2021;332:41-47.
    >> Share

  164. VERNON ST, Kott KA, Hansen T, Zhang KJ, et al
    Coronary artery disease burden in women poorly explained by traditional risk factors: Sex disaggregated analyses from the BioHEART-CT study.
    Atherosclerosis. 2021;333:100-107.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016